Sirolimus News and Research

RSS
OrbusNeich introduces COMBO Dual Therapy Stent

OrbusNeich introduces COMBO Dual Therapy Stent

DESolve bioresorbable coronary scaffold system safe and effective, shows low rates of late lumen loss

DESolve bioresorbable coronary scaffold system safe and effective, shows low rates of late lumen loss

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Targeted therapy prevents rare neurodevelopmental disorder seizures

Targeted therapy prevents rare neurodevelopmental disorder seizures

Drug alerts have variable impact on prescribing habits

Drug alerts have variable impact on prescribing habits

Sirolimus effective in treating children with Pretzel syndrome, new study reports

Sirolimus effective in treating children with Pretzel syndrome, new study reports

FDA accepts Merck's NDA for NOXAFIL tablets

FDA accepts Merck's NDA for NOXAFIL tablets

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Tacrolimus plus sirolimus not better than standard regimen in preventing GVHD

Tacrolimus plus sirolimus not better than standard regimen in preventing GVHD

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

CHOP presents new findings on pediatric cardiovascular disease at AHA 2012

CHOP presents new findings on pediatric cardiovascular disease at AHA 2012

Bone marrow transplants hold promise for sickle cell patients

Bone marrow transplants hold promise for sickle cell patients

Warning over sirolimus in HCV-positive liver transplantation

Warning over sirolimus in HCV-positive liver transplantation

PROTECT: Still no clear winner in the battle of the stent generations

PROTECT: Still no clear winner in the battle of the stent generations

Diabetes journal reports results from novel experimental therapy

Diabetes journal reports results from novel experimental therapy

Drug-eluting stents cleared for diabetes patients

Drug-eluting stents cleared for diabetes patients

Cardionovum to introduce PROLIMUS Biograde system in Europe

Cardionovum to introduce PROLIMUS Biograde system in Europe

Sirolimus has anti-skin cancer effect in kidney transplant patients

Sirolimus has anti-skin cancer effect in kidney transplant patients

SIR/TAC combination more effective in preventing GVHD after allogeneic blood cell transplantation

SIR/TAC combination more effective in preventing GVHD after allogeneic blood cell transplantation

STENTYS initiates enrollment in Self-Apposing Sirolimus-eluting stent trial for heart attack

STENTYS initiates enrollment in Self-Apposing Sirolimus-eluting stent trial for heart attack